{
    "Trade/Device Name(s)": [
        "EG V1 Pro Self Monitoring Blood Glucose Test System",
        "EG V1 (BL) Self Monitoring Blood Glucose Test System"
    ],
    "Submitter Information": "EPS Bio Technology Corp.",
    "510(k) Number": "k101037",
    "Predicate Device Reference 510(k) Number(s)": [
        "k062058"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "18 May 2011",
    "Summary Letter Received Date": "20 May 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Quality control materials (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Fresh capillary whole blood from fingertip",
        "Fresh capillary whole blood from palm",
        "Fresh capillary whole blood from forearm"
    ],
    "Specimen Container(s)": [
        "Heparin blood collection tube",
        "Single-use lancing device",
        "Auto-Lancet Device"
    ],
    "Instrument(s)/Platform(s)": [
        "EG V1 Pro meter",
        "EG V1 (BL) meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry",
        "Glucose Dehydrogenase (FAD) enzymatic reaction"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Dry reagent strip"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for EG V1 Pro and EG V1 (BL) Self Monitoring Blood Glucose Test Systems for quantitative measurement of glucose using electrochemical biosensor technology",
    "Indications for Use Summary": "EG V1 Pro: For quantitative measurement of glucose in venous or capillary whole blood (fingertip), intended for multiple-patient professional healthcare use, not for neonates or diagnosis/screening of diabetes; EG V1 (BL): For quantitative measurement of glucose in fresh capillary whole blood (fingertip, palm, forearm), intended for single-patient home use, not to be shared or used on neonates, nor for diagnosis/screening of diabetes",
    "fda_folder": "Clinical Chemistry"
}